2023 Form 5500 filing — Prime Therapeutics LLC 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241014102523NAL0027020273001) for Prime Therapeutics LLC 401(K) Plan, reported by Prime Therapeutics LLC under EIN 26-0076803 and plan number 001. It reports 7,502 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241014102523NAL0027020273001
Filing year
2023
Form type
2
Plan sponsor
Prime Therapeutics LLC
EIN
26-0076803
Plan number
001
Location
Eagan, MN
Participants
7,502
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$739,596,817
Total liabilities (EOY)
$0
Net assets (EOY)
$739,596,817
Employer contributions
$38,285,581
Participant contributions
$60,480,405
Total income / additions
$256,720,421
Benefits paid
$44,388,271
Administrative expenses
$444,266
Total expenses
$44,845,265
Net increase / (decrease)
$211,875,156
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Financial EnginesADVISOR$213,777not reported in the loaded dataset
Fidelity Investments InstitutionalRECORDKEEPER$143,732$0
SageviewCONSULTANT$51,750not reported in the loaded dataset
Bluecross Blue Shield AssociationOTHER SERVICES$20,181not reported in the loaded dataset
Cliftonlarsonallen LlpACCOUNTANT/AUDITOR$14,826not reported in the loaded dataset

Related Form 5500 pages